FDA Issues Class 1 Recall for Hospira GemStar Infusion for Battery Malfunction

An FDA Class 1 recall has been issued for Hospira’s GemStar Infusion System, a device for use in intravenous, arterial, subcutaneous, short-term infusion and parenteral administration of general IV fluids and medications, according to the American Society of Anesthesiologists.

Advertisement

FDA recalls Hospira GemStar Infusion SystemThe problem stems from the lithium battery voltage, which can drop below 2.4 volts and interrupt the device’s operations. The battery malfunction can also erase infusion settings and event history logs.

All lithium batteries older than three years should be replaced, according to the release. For more information, check with the FDA’s MedWatch Safety Information and Adverse Event Reporting Program.

More Articles on Anesthesia:
MEDNAX Acquires Georgia-based Gwinnett Anesthesia Service
Study: Neuraxial Anesthesia Better for Hip, Knee Arthroplasty
ASA Seeks Further Meaningful Use Exemptions for Anesthesiologists

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in Anesthesia

Advertisement

Comments are closed.